Front Row Advisors LLC - GT BIOPHARMA INC ownership

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$14580.0%0.00%
Q2 2023$0580.0%0.00%
Q1 2023$0580.00%
Other shareholders
GT BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$470.01%
McCollum Christoferson Group LLC 17,500$5,4600.00%
Moss Adams Wealth Advisors LLC 10,000$3,1200.00%
JANE STREET GROUP, LLC 20,501$6,3960.00%
Cubist Systematic Strategies, LLC 10,458$3,2630.00%
Point72 Asset Management, L.P. 1$00.00%
UBS Group AG 3,033$9460.00%
Compagnie Lombard Odier SCmA 50,000$15,6000.00%
IFP Advisors, Inc 100$2750.00%
OSAIC HOLDINGS, INC. 1,017$3160.00%
View complete list of GT BIOPHARMA INC shareholders